Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle

FEBS Letters

Volumn 581, Issue 4, 2007, Pages 587-595

  Bailey, Leslie ^a   Gylfe, Åsa ^a   Sundin, Charlotta ^c   Muschiol, Sandra ^b   Elofsson, Mikael ^a   Nordström, Peter ^a   Henriques Normark, Birgitta ^b   Lugert, Raimond ^d   Waldenström, Anders ^a   Wolf Watz, Hans ^a   Bergström, Sven ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Innate Pharmaceuticals AB   (Sweden)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chemical genetics; Chlamydia; Inhibitors; Type III secretion; Yersinia

Indexed keywords

HYDRAZONE DERIVATIVE; INP 0007; INP 0010; INP 0400; INP 0406; SALICYLALDEHYDE; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DRUG IDENTIFICATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; TYPE III SECRETION SYSTEM; YERSINIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL PROLIFERATION; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; HELA CELLS; HUMANS; MICE; TRANSCRIPTION, GENETIC; YERSINIA INFECTIONS; YERSINIA PSEUDOTUBERCULOSIS;

CHLAMYDIA; CHLAMYDIALES; CHLAMYDOPHILA PNEUMONIAE; YERSINIA;

EID: 33846878999     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.01.013     Document Type: Article

References (21)

1. Abdelrahman Y.M., and Belland R.J. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29 (2005) 949-959
2. Read T.D., et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28 (2000) 1397-1406
3. Stephens R.S., et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282 (1998) 754-759
4. Kalman S., et al. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21 (1999) 385-389
5. Ouellette S.P., Abdelrahman Y.M., Belland R.J., and Byrne G.I. The Chlamydia pneumoniae type III secretion-related lcrH gene clusters are developmentally expressed operons. J. Bacteriol. 187 (2005) 7853-7856
6. Fields K.A., Mead D.J., Dooley C.A., and Hackstadt T. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol. Microbiol. 48 (2003) 671-683
7. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62 (1998) 379-433
8. Lugert R., Kuhns M., Polch T., and Gross U. Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae. Med. Microbiol. Immunol. (Berl.) 193 (2004) 163-171
9. Slepenkin A., Motin V., de la Maza L.M., and Peterson E.M. Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect. Immun. 71 (2003) 2555-2562
10. Clifton D.R., Dooley C.A., Grieshaber S.S., Carabeo R.A., Fields K.A., and Hackstadt T. Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin. Infect Immun. 73 (2005) 3860-3868
11. Clifton D.R., Fields K.A., Grieshaber S.S., Dooley C.A., Fischer E.R., Mead D.J., Carabeo R.A., and Hackstadt T. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc. Natl. Acad. Sci. USA 101 (2004) 10166-10171
12. Subtil A., Parsot C., and Dautry-Varsat A. Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol. Microbiol. 39 (2001) 792-800
13. Kauppi A.M., Nordfelth R., Uvell H., Wolf-Watz H., and Elofsson M. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10 (2003) 241-249
14. Nordfelth R., Kauppi A.M., Norberg H.A., Wolf-Watz H., and Elofsson M. Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73 (2005) 3104-3114
15. Muschiol S., et al. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 103 (2006) 14566-14571
16. Wolf K., Betts H.J., Chellas-Gery B., Hower S., Linton C.N., and Fields K.A. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61 (2006) 1543-1555
17. Sundin C., Henriksson M.L., Hallberg B., Forsberg A., and Frithz-Lindsten E. Exoenzyme T of Pseudomonas aeruginosa elicits cytotoxicity without interfering with Ras signal transduction. Cell Microbiol. 3 (2001) 237-246
18. Kuoppa Y., Boman J., Scott L., Kumlin U., Eriksson I., and Allard A. Quantitative detection of respiratory Chlamydia pneumoniae infection by real-time PCR. J. Clin. Microbiol. 40 (2002) 2273-2274
19. Monack D.M., Mecsas J., Ghori N., and Falkow S. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. USA 94 (1997) 10385-10390
20. Schesser K., Spiik A.K., Dukuzumuremyi J.M., Neurath M.F., Pettersson S., and Wolf-Watz H. The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol. Microbiol. 28 (1998) 1067-1079
21. Cornelis G.R., and Wolf-Watz H. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23 (1997) 861-867